The Effect of Late Doses on the Achievement of Seroprotection and Antibody Titer Levels With Hepatitis B Immunization Among Adolescents

Publisher Website
Google Scholar
Abstract
Objective. To determine the effect of varying dosing schedules and predictor variables on the seroprotection rates and geometric mean titer levels resulting from the hepatitis B vaccination series among adolescents. Methods. Adolescents received the hepatitis B vaccination series at varying schedules according to their natural adherence patterns. Data collected included participants9 medication use; chronic illness; use of cigarettes, alcohol, and marijuana; age; race/ethnicity; and body mass index. Participants9 dates of vaccinations were recorded and titer levels for hepatitis B surface antibody were drawn ∼12 and 24 months after study enrollment. The data for 498 participants were analyzed using χ2 tests, Student t tests, logistic regression models, and analysis of variance. Results. Seroprotection rates among adolescents were not affected by late vaccinations. The only factors affecting the achievement of seroprotection ∼12 and 24 months after the first vaccination were body mass index and the number of immunizations received. Increased time between doses 1 and 2 and doses 2 and 3 showed a trend toward correlating with increasing titer levels. Conclusions. Although adolescents at risk of acquiring hepatitis B should receive the hepatitis B vaccination series in a timely fashion, late doses are not detrimental, and may be beneficial, to achieving high antibody levels against the hepatitis B virus.